Intrinsiqq
Evaxion A/S American logo

Evaxion A/S American

EVAX

Compare

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$17M
EPS-$1.50
P/E-1.51
P/FCF–
EV/EBITDA-0.13
FCF Yield–
Div. Yield–
Net Debt/FCF–
Evaxion A/S American intrinsic value
52-Week Range
$2.03$6.63

Profitability & Returns

Revenue (TTM)

$7M

▲ +125.1% YoY

Net Income (TTM)

-$9M

▲ +27.1% YoY

Op. Margin

-116.04%

▲ +317.9pp YoY

ROIC

-42.11%

▲ +68.9pp YoY

Cash Flow & Balance Sheet

FCF (FY)

-$7M

▲ +48.7% YoY

Op. Cash Flow (FY)

-$7M

▲ +26.0% YoY

Net Debt

-$16M

Net Cash Position

Cash & Equiv.

$23M

Continue Research

Peers

Biotechnology · Pick stocks to compare with EVAX

CompareIntrinsic value
HPHA.XETRHeidelberg Pharma AG
€2.01-2.90%10
ACOU.XSTOAcousort AB
€0.22+0.45%40
BIG1.XETRBio-Gate AG
€2.06+3.00%36
IMRNImmuron Ltd. Sponsored ADR
$0.90+5.86%40
HYL.XBRUHyloris Pharmaceuticals SA
€4.15-3.49%46
ABLD.XPARABL Diagnostics S.A.
€2.34+0.00%46
ACARIX.XSTOAcarix AB
€0.01+0.00%40
ALMKT.XPARMauna Kea Technologies S.A.
€0.09-2.79%18

Evaxion A/S American (EVAX) in four numbers

Fair value (revenue)
$7.41
Price $2.26 is 70% below it.
Intrinsic Value
Quality score
10/100
Best check: net debt, -$16M. Weakest: return on capital, -42.1%.
Quality
Dividend
None
No dividend in the company filings we hold.
Dividends
P/E
-1.51
Negative: a loss over the last twelve months.
Financials

Questions about Evaxion A/S American

Is Evaxion A/S American (EVAX) overvalued?

At $2.26, Evaxion A/S American's price is 70% below the $7.41 a share fair value that Intrinsiqq's calculator gets from its revenue. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.

What is Evaxion A/S American's fair value?

Intrinsiqq's calculator puts Evaxion A/S American's fair value at $7.41 a share. It grows revenue per share 30% a year for 5 years, applies an exit P/S of 3.2, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of $5.56. Every input can be changed on the Intrinsic Value tab.

Is Evaxion A/S American a high-quality business?

Evaxion A/S American scores 10 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 4 checks computed from company filings. Its best check is net debt at -$16M, and its weakest is return on capital at -42.1%. The Quality tab shows every check against its target.

Does Evaxion A/S American (EVAX) pay a dividend?

No. Evaxion A/S American (EVAX) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: company filings. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing EVAX

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.